Research is just starting to explore how different conditions affect female-bodied people differently to male-bodied people. One of these areas in particular is in autoimmune conditions, where the immune system treats healthy tissues and cells as if they’re threats. Some of the most common autoimmune diseases show up differently in men and women. That can lead to confusion about what autoimmune conditions ‘typically’ look like, particularly if you’re a woman searching for a diagnosis — so it’s important to get the differences right.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.
